Apoptotic cell death and cytokine dysregulation in human immunodeficiency virus infection: Pivotal factors in disease progression

Cell Death and Differentiation

Volumn 4, Issue 8, 1997, Pages 699-706

  Clerici, Mario ^a,c   Sarin, Apurva ^b   Henkart, Pierre A ^b   Shearer, Gene M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000454244     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400314     Document Type: Article

References (15)

1. Ameisen JC and Capron A (1991) Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12: 102-106
2. Ameisen J-C (1994) Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS 8: 1197-1213
3. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F and Lynch DH (1995) Fas ligand mediates activation-induced cell death in human T cell lymphocytes. J. Exp. Med. 181: 71-77
4. Badley AD, Dockrell D, Simpson M, Schut R, Lynch DH, Leibson P and Paya CV (1997) Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and TNF. J. Exp. Med. 185:
5. 55-64 Ito N, Yoncara S, Ishij A, Yoncard M, Mitsushima S, Sameshima M, Hase A, Sato Y and Nagata N (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediated apoptosis. Cell 75: 1169-1178
6. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stunger BZ and Marshak-Rothstein A (1995) Fas (CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 373: 444-448
7. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA and Herzenberg LA (1995) Fas antigern stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus infected individuals. J. Exp. Med. 181: 2029-2036
8. Kelleher AD, Carr A, Zaunders J and Cooper DA (1996) Alterations in the immune response of HIV-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis. 173: 321-329
9. Lucey DR, Melchers GP, Hendrix CW et al (1991) The US AirForce HIV study 1985-1990: immunological analyses, seroconversion and the potential utility of a T helper functional assay to predict change in CD4+ T-cell counts during early stages of HIV infection. J. Infect. Dis. 164: 631-637
10. McCloskey TW, Oyazu N, Kaplan M, Pahwa S (1995) Expression of the Fas antigen on patients infected with HIV. Cytometry 22: 111-114
11. Medrano FJ, Leal M, Arienti D, Rey C, Zagliani A, Torres Y, Lissen E and Clerici M (1997) Tumor necrosis factor β and soluble APO-1/Fas independently predict. progression to AIDS in HIV seropositive patients. J. Inf. Dis. in press
12. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM and Miedema F (1992) Programmed cell death of T cells in HIV infection. Science 257: 217-219
13. Miedema F, Petit AJ and Terpstra FG (1988) Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Clin. Invest. 82: 1908-1916
14. Nagata S and Golstein P (1995) The Fas death factor. Science 257: 1449-1456
15. Yonehara S, Ishij A and Yoncara M (1989) A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the TNF receptor. J. Exp. Med. 169: 1747-1756 11811-11815